Rollout...

 

Nearly everything about the process has gone well so far, shepherded by the Trump administration's Operation Warp Speed.

The first two vaccines, one from Pfizer-BioNTech and the other from Moderna, were ready well before anyone expected. 

Trials showed them to be among the most effective vaccines ever, particularly for a notoriously hard-to-prevent respiratory virus.

And the initial days of the rollout, while far from perfect, have already led to 3 million vaccinations in the U.S., mostly among frontline health care workers.

Good news for the holidays. So far so good. Just a thought.